Free sleep sits at the center of this dementia and brain health question.

There isn’t currently a single free sleep assessment tool available to the general public that neurologists use specifically for dementia screening, despite what headlines might suggest. However, emerging research is rapidly changing this landscape.

Scientists are developing sleep-based biomarkers—measurements derived from how you sleep—that can detect early signs of Alzheimer’s disease and cognitive decline with remarkable accuracy, sometimes even before symptoms appear. The Dementia Research Institute Sleep Index (DRI-SI), tested in the InSleep46 study, represents one of the most promising advances, using a simple under-mattress sensor to analyze sleep patterns for signs of neurodegeneration. This article explores the cutting-edge sleep technologies being tested, why current neurological screening tools matter, and how you can stay informed about tools that may soon become available to you.

Why Sleep Patterns Matter for Detecting Dementia Risk
The Emerging Sleep-Based Biomarkers Scientists Are Testing
The Connection Between Sleep Quality and Cognitive Decline
What Neurologists Actually Use Today for Dementia Screening
Why These Sleep Tools Aren’t Yet Available to Consumers
What You Can Do Now If You’re Concerned About Dementia Risk
What the Future Holds for Sleep-Based Dementia Detection
Conclusion

Why Sleep Patterns Matter for Detecting Dementia Risk

sleep disturbances are often an early warning sign of cognitive decline, sometimes appearing years before noticeable memory loss or confusion. Research from 2025 shows that chronic insomnia alone may increase dementia risk by as much as 40%—a significant finding that’s reshaping how researchers think about prevention. Beyond insomnia, sleep apnea and other sleep disorders have long been associated with cognitive decline and increased dementia risk. What makes this compelling is that sleep problems are measurable and potentially modifiable through intervention.

If detecting sleep changes could catch dementia risk early, treatments or lifestyle modifications might slow cognitive decline before it becomes noticeable. The reason neurologists are interested in sleep as a screening tool is straightforward: unlike a cognitive test that requires you to visit a clinic and perform tasks, sleep monitoring can happen continuously in your own home. You sleep anyway—so a tool that could flag risk without adding any burden to your routine is tremendously appealing. This is why researchers have pivoted from traditional office-based assessments to wearable and in-home monitoring technologies.

Why Sleep Patterns Matter for Detecting Dementia Risk

The Emerging Sleep-Based Biomarkers Scientists Are Testing

The most well-known research project testing sleep for dementia detection is the InSleep46 study, which uses the Withings Sleep Analyzer—an under-mattress pressure sensor that costs approximately $130 to $200. This device measures sleep architecture (how much time you spend in different sleep stages), breathing patterns, and heart rate variability. Researchers are exploring whether these metrics can identify Alzheimer’s disease-related changes in people who show no cognitive symptoms yet. The DRI-SI, or Dementia Research Institute Sleep Index, is the digital biomarker emerging from this work—essentially an algorithm that combines multiple sleep measurements into a single risk score. Alongside sensor-based approaches, wearable sleep recording combined with artificial intelligence has shown remarkable promise.

Recent research achieved 90% accuracy in detecting Alzheimer’s disease using multimodal data from wearables—combining information from accelerometers (movement), EEG (brain waves), and other sensors. Another approach, the Brain Age Index derived from sleep EEG, uses machine learning to analyze 13 age-dependent features in your sleep brainwaves and predict cognitive decline risk. However, it’s important to understand that none of these tools are currently available as free assessments to the general public. They exist in research studies with limited enrollment, or they require purchasing a device and waiting for validation before any clinical recommendation. The InSleep46 study, for instance, is still actively recruiting and analyzing data.

The Connection Between Sleep Quality and Cognitive Decline

The relationship between sleep and dementia risk is bidirectional and complex. Sleep disturbances don’t just correlate with dementia—they may actively contribute to it. During sleep, your brain clears out metabolic waste products, including amyloid-beta and tau proteins, which accumulate in Alzheimer’s disease. When sleep is disrupted, this clearing process is less efficient, potentially allowing harmful proteins to build up. This mechanism explains why people with sleep apnea—where breathing repeatedly stops during sleep—have elevated dementia risk.

Each apnea episode disrupts sleep architecture and reduces oxygen delivery to the brain. What’s particularly important to understand is that sleep problems often precede cognitive symptoms by years. Someone might experience increasing insomnia or fragmented sleep for five to ten years before developing noticeable memory issues. This makes sleep an excellent early-warning signal, if we had tools to recognize it. The Mayo Clinic research finding that chronic insomnia increases dementia risk by 40% underscores this: a treatable problem (insomnia) is statistically linked to a serious outcome (dementia), suggesting that intervention might change the trajectory.

The Connection Between Sleep Quality and Cognitive Decline

What Neurologists Actually Use Today for Dementia Screening

While sleep-based tools are still in development, neurologists currently rely on established cognitive screening tests. The Mini-Cog exam takes only five minutes and involves asking you to recall three words and draw a clock—surprisingly effective at catching early cognitive impairment. The MMSE (Mini-Mental State Examination) is more comprehensive but takes longer, assessing orientation, memory, attention, and language. The MoCA (Montreal Cognitive Assessment) is considered more sensitive to subtle cognitive changes and is increasingly used in primary care.

The limitation of these tests is obvious: you have to schedule an appointment and perform under observation. Many people never take them because they don’t suspect a problem. Additionally, these tests measure cognitive function at a single moment in time; they can’t track gradual decline unless you repeat them periodically. This is why sleep-based biomarkers are so appealing to researchers—they could provide continuous, passive monitoring in your home. But for now, if you’re concerned about dementia risk, these cognitive screening tools remain the standard approach your doctor would recommend.

Why These Sleep Tools Aren’t Yet Available to Consumers

The gap between research success and real-world availability exists for important reasons. Even though wearable sleep monitoring shows 90% accuracy in detecting Alzheimer’s in research settings, that accuracy was demonstrated on a specific population in a controlled study. Before a tool can be recommended for general screening, researchers must validate it across diverse populations—different ages, races, sexes, and health backgrounds. They must confirm that the algorithm works just as well in someone’s actual bedroom as it did in the lab. They must also establish what a “positive” result means clinically and determine if catching early dementia biomarkers actually changes patient outcomes for the better.

The Withings Sleep Analyzer itself is a consumer product, but using it as a dementia screening tool remains experimental. You could buy one today, but no neurologist would interpret your sleep data as a dementia risk assessment—the science isn’t there yet. The InSleep46 study is actively working toward this goal, but it will take time. Additionally, any future clinical tool would need regulatory approval (like FDA clearance), which adds years to the timeline. Until then, sleep monitoring remains a research tool, not a clinical screening tool.

Why These Sleep Tools Aren't Yet Available to Consumers

What You Can Do Now If You’re Concerned About Dementia Risk

If you’ve experienced changes in your sleep or are worried about cognitive decline, several concrete steps don’t require waiting for new tools. First, mention sleep changes to your primary care doctor—insomnia, sleep apnea, or frequent nighttime awakenings are worth investigating regardless of dementia risk. Sleep apnea especially is common, treatable, and associated with multiple serious health conditions beyond dementia. Your doctor can refer you for a sleep study if needed.

Second, if you want to get a cognitive assessment now, ask your doctor about the Mini-Cog or another screening test. These are quick, free or low-cost through most healthcare systems, and they give you a baseline. If you’re over 65 or have risk factors (family history, hypertension, diabetes), periodic screening is reasonable. Third, optimize your sleep through proven methods: consistent sleep schedule, cool dark bedroom, limiting alcohol and screens before bed, and exercise during the day. These interventions improve sleep quality and may reduce dementia risk through multiple biological pathways.

What the Future Holds for Sleep-Based Dementia Detection

The trajectory is clear: sleep monitoring will become part of dementia screening within the next five to ten years, as research continues to validate these tools. The InSleep46 study and similar projects are laying the foundation. As wearable technology improves and becomes more affordable, continuous home-based monitoring of sleep could eventually flag cognitive risk the way wearable devices now flag irregular heart rhythms. What’s uncertain is whether these tools will be free, subsidized, or require purchase—that depends on regulatory pathways and how healthcare systems decide to integrate them.

One emerging possibility is that sleep data collected by existing consumer devices—smartwatches, fitness trackers, even smartphone sleep-tracking apps—could eventually be analyzed for dementia risk signals. However, this raises privacy and data security questions that are still being worked out. The future likely involves integration: your sleep data feeds into an algorithm that combines it with other information (cognitive tests, genetic risk, biomarkers from blood tests) to give a comprehensive dementia risk profile. That’s the direction research is moving, and it’s far more powerful than any single measurement alone.

Conclusion

The short answer to the question posed by the title is that a free, validated sleep assessment tool for dementia screening doesn’t yet exist for the general public, despite promising research showing it could work. What does exist are emerging technologies like the DRI-SI and multimodal wearable analysis, which are being tested in studies like InSleep46 but aren’t ready for clinical use. The science is clear that sleep disturbances—particularly chronic insomnia, which increases dementia risk by 40%, and sleep apnea—are associated with cognitive decline and may be early warning signs of dementia.

If you’re concerned about your dementia risk, don’t wait for new tools to become available. Start by discussing sleep quality and cognitive concerns with your doctor, get a cognitive screening like the Mini-Cog if recommended, and address any sleep disorders you might have. The next five to ten years will likely bring sleep-based screening into clinical practice, but in the meantime, taking sleep seriously and staying alert to cognitive changes remains your best strategy.